Definitive Healthcare (NASDAQ:DH) was given a new $2.75 price target on by analysts at Barclays PLC.
Definitive Healthcare (NASDAQ:DH) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $5.00 to $4.00. They now have a "hold" rating on the stock.
Analysts Have Been Trimming Their Definitive Healthcare Corp. (NASDAQ:DH) Price Target After Its Latest Report [Yahoo! Finance]
Definitive Healthcare (NASDAQ:DH) was upgraded by analysts at William Blair to a "strong-buy" rating.
Definitive Healthcare Corp. (DH) Q3 2025 Earnings Call Transcript [Seeking Alpha]